ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 61 filers reported holding ESSA PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,171,000 | -57.3% | 2,909,410 | -16.2% | 0.01% | -40.0% |
| Q1 2022 | $21,466,000 | -55.6% | 3,472,800 | +2.0% | 0.01% | -50.0% |
| Q4 2021 | $48,304,000 | +73.5% | 3,404,707 | -2.1% | 0.02% | +66.7% |
| Q3 2021 | $27,837,000 | -51.7% | 3,477,844 | +72.4% | 0.01% | -52.0% |
| Q2 2021 | $57,677,000 | +31.0% | 2,017,894 | +33.1% | 0.02% | +25.0% |
| Q1 2021 | $44,032,000 | +634.5% | 1,516,102 | +197.8% | 0.02% | +566.7% |
| Q4 2020 | $5,995,000 | +84.1% | 509,095 | +7.0% | 0.00% | +50.0% |
| Q3 2020 | $3,256,000 | +32.6% | 475,688 | +18.4% | 0.00% | +100.0% |
| Q2 2020 | $2,456,000 | +208.5% | 401,596 | +102.0% | 0.00% | 0.0% |
| Q1 2020 | $796,000 | – | 198,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |